Faculty
John DiPersio.jpg

John F. DiPersio, MD, PhD

Professor
Department of Medicine
Oncology Division
Bone Marrow Transplantation & Leukemia
Stem Cell Biology
Department of Pediatrics
Department of Pathology & Immunology

Clinical Interests

  • Allogeneic stem cell transplantation
  • Haploidentical stem cell transplantation

Research Interests

  • Hematopoietic growth factor receptors
  • Murine models of graft-versus-host disease and graft-versus-leukemia
  • Leukemia genomics

Contact

  • 314-454-8306 (tel)
  • 314-454-7551 (fax)
  • 11th Floor Mid-Campus Center (office)
  • 626 Southwest Tower (lab)
  • Division of Oncology
    Campus Box 8007
    Washington University Medical School
    660 South Euclid Avenue
    St. Louis, MO 63110

Publications

  • Haploidentical Hematopoietic Cell Transplant With Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults With Acute Myeloid Leukemia or Myelodysplastic Syndrome
    Slade M, DiPersio JF, Westervelt P, Vij R, Schroeder MA, Romee R
    Biol Blood Marrow Transplant 2017 Oct;23(10):1736-1743
  • Lack of Prognostic Impact of MyD88 L265P Mutation for DLBCL Patients Undergoing Autologous Stem Cell Transplantation
    Lee YS, Liu J, Fricano KA, Webb EM, Toolsie DR, Jones S, Rhoads JA, Vij R, Cashen AF, Abboud CN, Westervelt P, Bartlett NL, DiPersio JF, Kreisel FH, Lim KH
    Biol Blood Marrow Transplant 2017 Aug 25; [Epub ahead of print]
  • Results of prospective randomized, open label, non-inferiority study of Tbo-filgrastim (Granix(R)) versus filgrastim (Neupogen(R)) in combination with plerixafor for autologous stem cell mobilization in patients with multiple myeloma or non-Hodgkin lymphoma
    Bhamidipati PK, Fiala MA, Grossman BJ, DiPersio JF, Stockerl-GoldsteinK, Gao F, Uy GL, Westervelt P, Schroeder MA, Cashen AF, Abboud CN, Vij R
    Biol Blood Marrow Transplant 2017 Aug 7; [Epub ahead of print]
  • Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state
    Rashidi A, Ali AM, Vij KR, Shanley R, Romee R, Cooley SA, Westervelt P, DiPersio JF, Miller JS, Weisdorf DJ, Ustun C
    Am J Hematol 2017 Sep;92(9):E549-E552
  • Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia
    Khoury HJ, Collins RH Jr, Blum W, Stiff PS, Elias L, Lebkowski JS, Reddy A, Nishimoto KP, Sen D, Wirth ED 3rd, Case CC, DiPersio JF
    Cancer 2017 Aug 15;123(16):3061-3072
  • Fresh or cryopreserved CD34+-selected mobilized peripheral blood stem and progenitor cells for the treatment of poor graft function after allogeneic hematopoietic cell transplantation
    Ghobadi A, Fiala MA, Ramsingh G, Gao F, Abboud CN, Stockerl-Goldstein K, Uy GL, Grossman BJ, Westervelt P, DiPersio JF
    Biol Blood Marrow Transplant 2017 Jul;23(7):1072-1077
  • Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study
    Goyal S, Oak E, Luo J, Cashen AF, Carson K, Fehniger T, DiPersio J, Bartlett NL, Wagner-Johnston ND
    Leuk Lymphoma 2017 Jun 9:1-6; [Epub ahead of print]
  • Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells
    Karpova D, Ritchey JK, Holt MS, Abou-Ezzi G, Monlish D, Batoon L, Millard S, Spohn G, Wiercinska E, Chendamarai E, Yang W, Christ S, Gehrs L, Schuettpelz LG, Dembowsky K, Pettit AR, Rettig MP, Bonig H, DiPersio JF
    Blood 2017 May 25;129(21):2939-2949
  • Phase I/II study of intravenous plerixafor added to a mobilization regimen of granulocyte colony-stimulating factor in lymphoma patients undergoing autologous stem cell collection
    Cashen AF, Rettig M, Gao F, Smith A, Abboud C, Stockerl-Goldstein K, Vij R, Uy G, Westervelt P, DiPersio J
    Biol Blood Marrow Transplant 2017 Aug;23(8):1282-1289
  • Risk for Clostridium difficile infection after allogeneic hematopoietic cell transplant remains elevated in the postengraftment period
    Dubberke ER, Reske KA, Olsen MA, Bommarito KM, Seiler S, Silveira FP, Chiller TM, DiPersio J, Fraser VJ
    Transplant Direct 2017 Mar 17;3(4):e145
  • Azacitidine mitigates graft-versus-host disease via differential effects on the proliferation of T effectors and natural regulatory T cells in vivo
    Cooper ML, Choi J, Karpova D, Vij K, Ritchey J, Schroeder MA, DiPersio JF
    J Immunol 2017 May 1;198(9):3746-3754
  • T cell-replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplantation cyclophosphamide results in outcomes similar to transplantation from traditionally matched donors in active disease acute myeloid leukemia
    How J, Slade M, Vu K, DiPersio JF, Westervelt P, Uy GL, Abboud CN, Vij R, Schroeder MA, Fehniger TA, Romee R
    Biol Blood Marrow Transplant 2017 Apr;23(4):648-653
  • Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft
    Schroeder MA, Rettig MP, Lopez S, Christ S, Fiala M, Eades W, Mir FA, Shao J, McFarland K, Trinkaus K, Shannon W, Deych E, Yu J, Vij R, Stockerl-Goldstein K, Cashen AF, Uy GL, Abboud CN, Westervelt P, DiPersio JF
    Blood 2017 May 11;129(19):2680-2692
  • A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia
    Uy GL, Rettig MP, Stone RM, Konopleva MY, Andreeff M, McFarland K, Shannon W, Fletcher TR, Reineck T, Eades W, Stockerl-Goldstein K, Abboud CN, Jacoby MA, Westervelt P, DiPersio JF
    Blood Cancer J 2017 Mar 10;7(3):e542
  • Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy
    Duncavage EJ, Uy GL, Petti AA, Miller CA, Lee YS, Tandon B, Gao F, Fronick CC, O'Laughlin M, Fulton RS, Wilson RK, Jacoby MA, Cashen AF, Wartman LD, Walter MJ, Westervelt P, Link DC, DiPersio JF, Ley TJ, Welch JS
    Blood 2017 Mar 9;129(10):1397-1401
  • Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation
    Lin CJ, Vader JM, Slade M, DiPersio JF, Westervelt P, Romee R
    Cancer 2017 May 15;123(10):1800-1809
  • CpG island hypermethylation mediated by DNMT3A is a consequence of AML progression
    Spencer DH, Russler-Germain DA, Ketkar S, Helton NM, Lamprecht TL, Fulton RS, Fronick CC, O'Laughlin M, Heath SE, Shinawi M, Westervelt P, Payton JE, Wartman LD, Welch JS, Wilson RK, Walter MJ, Link DC, DiPersio JF, Ley TJ
    Cell 2017 Feb 23;168(5):801-816
  • Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial
    Verstovsek S, Mesa RA, Gotlib J, Gupta V, DiPersio JF, Catalano JV, Deininger MW, Miller CB, Silver RT, Talpaz M, Winton EF, Harvey JH Jr, Arcasoy MO, Hexner EO, Lyons RM, Paquette R, Raza A, Jones M, Kornacki D, Sun K, Kantarjian H
    COMFORT-I investigators

    J Hematol Oncol 2017 Feb 22;10(1):55
  • Tissue polymerase chain reaction for the diagnosis of cytomegalovirus disease after allogeneic hematopoietic cell transplantation
    Rashidi A, Vij KR, Buller RS, Wylie KM, Storch GA, DiPersio JF
    Am J Hematol 2017 Feb;92(2):E19-E20
  • A proposed biology- and biomarker-based algorithm for management of acute GvHD
    Ali AM, DiPersio JF, Schroeder MA
    Bone Marrow Transplant 2017 Feb;52(2):337-340
  • Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation
    Slade M, Goldsmith S, Romee R, DiPersio JF, Dubberke ER, Westervelt P, Uy GL, Lawrence SJ
    Transpl Infect Dis 2017 Feb;19(1):e12629
  • Antileukemia efficacy and mechanisms of action of SL-101, a novel anti-CD123 antibody conjugate, in acute myeloid leukemia
    Han L, Jorgensen JL, Brooks C, Shi C, Zhang Q, Nogueras Gonzalez GM, Cavazos A, Pan R, Mu H, Wang SA, Zhou J, Ai-Atrash G, Ciurea SO, Rettig M, DiPersio JF, Cortes J, Huang X, Kantarjian HM, Andreeff M, Ravandi F, Konopleva M
    Clin Cancer Res 2017 Jul 1;23(13):3385-3395
  • Single institution experience with G-CSF mobilized T-cell replete haploidentical hematopoietic cell transplantation
    Huselton E, Slade M, DiPersio JF, Westervelt P, Vij R, Uy GL, Fehniger TA, Abboud CN, Gao F, Schroeder MA, Romee R
    Bone Marrow Transplant 2017 May;52(5):769-771
  • Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy
    Uy GL, Duncavage EJ, Chang GS, Jacoby MA, Miller CA, Shao J, Heath S, Elliott K, Reineck T, Fulton RS, Fronick CC, O'Laughlin M, Ganel L, Abboud CN, Cashen AF, DiPersio JF, Wilson RK, Link DC, Welch JS, Ley TJ, Graubert TA, Westervelt P, Walter MJ
    Leukemia 2017 Apr;31(4):872-881
  • Acute lymphoblastic leukemia presenting with hypereosinophilia: case report and review of the literature
    Ali AM, Rashidi A, DiPersio JF
    Blood Cells Mol Dis 2017 Jun;65:97-100
  • The impact of diabetes mellitus and other comorbidities on hematopoietic stem cell collection and hematologic recovery post-transplantation
    Fiala MA, Slade M, Wang S, Park S, DiPersio J, Stockerl-Goldstein K
    Leuk Lymphoma 2017 Jan;58(1):241-243
  • TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes
    Welch JS, Petti AA, Miller CA, Fronick CC, O'Laughlin M, Fulton RS, Wilson RK, Baty JD, Duncavage EJ, Tandon B, Lee YS, Wartman LD, Uy GL, Ghobadi A, Tomasson MH, Pusic I, Romee R, Fehniger TA, Stockerl-Goldstein KE, Vij R, Oh ST, Abboud CN, Cashen AF, Schroeder MA, Jacoby MA, Heath SE, Luber K, Janke MR, Hantel A, Khan N, Sukhanova MJ, Knoebel RW, Stock W, Graubert TA, Walter MJ, Westervelt P, Link DC, DiPersio JF, Ley TJ
    N Engl J Med 2016 Nov 24;375(21):2023-2036
  • Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation
    Ghobadi A, Choi J, Fiala MA, Fletcher T, Liu J, Eissenberg LG, Abboud C, Cashen A, Vij R, Schroeder MA, Pusic I, Stockerl-Goldstein K, Jacoby M, Uy G, DiPersio J, Westervelt P
    Leuk Res 2016 Oct;49:1-6
  • Enhanced in utero allogeneic engraftment in mice after mobilizing fetal HSCs by alpha4beta1/7 inhibition
    Kim AG, Vrecenak JD, Boelig MM, Eissenberg L, Rettig MP, Riley JS, Holt MS, Conner MA, Loukogeorgakis SP, Li H, DiPersio JF, Flake AW, Peranteau WH
    Blood 2016 Nov 17;128(20):2457-2461
  • Phase II study of propylene glycol-free melphalan combined with carmustine, etoposide, and cytarabine for myeloablative conditioning in lymphoma patients undergoing autologous stem cell transplantation
    Cashen AF, Fletcher T, Ceriotti C, Gao F, Ghobadi A, Vij R, Stockerl-Goldstein K, DiPersio J, Abboud C
    Biol Blood Marrow Transplant 2016 Dec;22(12):2155-2158
  • Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML
    Rashidi A, Slade M, DiPersio JF, Westervelt P, Vij R, Romee R
    Bone Marrow Transplant 2016 Dec;51(12):1561-1564
  • Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide
    Goldsmith SR, Slade M, DiPersio JF, Westervelt P, Lawrence SJ, Uy GL, Abboud CN, Vij R, Schroeder MA, Fehniger TA, Dubberke ER, Trinkaus K, Romee R
    Haematologica 2016 Nov;101(11):e465-e468
  • Maintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials
    Rashidi A, Walter RB, Tallman MS, Appelbaum FR, DiPersio JF
    Blood 2016 Aug 11;128(6):763-73
  • Divergent viral presentation among human tumors and adjacent normal tissues
    Cao S, Wendl MC, Wyczalkowski MA, Wylie K, Ye K, Jayasinghe R, Xie M, Wu S, Niu B, Grubb R 3rd, Johnson KJ, Gay H, Chen K, Rader JS, DiPersio JF, Chen F, Ding L
    Sci Rep 2016 Jun 24;6:28294
  • Severe cytokine-release syndrome after T cell-replete peripheral blood haploidentical donor transplantation is associated with poor survival and anti-IL-6 therapy is safe and well tolerated
    Abboud R, Keller J, Slade M, DiPersio JF, Westervelt P, Rettig MP, Meier S, Fehniger TA, Abboud CN, Uy GL, Vij R, Trinkaus KM, Schroeder MA, Romee R
    Biol Blood Marrow Transplant 2016 Oct;22(10):1851-60
  • Remobilization of hematopoietic stem cells in healthy donors for allogeneic transplantation
    Fiala MA, Park S, Slade M, DiPersio JF, Stockerl-Goldstein KE
    Transfusion 2016 Sep;56(9):2331-5
  • Quality of life: a tiebreaker in CEBPA double-mutated acute myeloid leukemia
    Rashidi A, DiPersio JF
    Biol Blood Marrow Transplant 2016 Aug;22(8):1535-1536
  • Do adults aged 70 years or older with acute myeloid leukemia benefit from allogeneic hematopoietic cell transplantation?
    Rashidi A, DiPersio JF, Westervelt P, Vij R, Abboud CN, Romee R
    Leukemia 2016 Aug;30(8):1797-9
  • Comparison of outcomes after peripheral blood haploidentical versus matched unrelated donor allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia: a retrospective single-center review
    Rashidi A, DiPersio JF, Westervelt P, Vij R, Schroeder MA, Cashen AF, Fehniger TA, Romee R
    Biol Blood Marrow Transplant 2016 Sep;22(9):1696-701
  • Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia
    Griffith M, Griffith OL, Krysiak K, Skidmore ZL, Christopher MJ, Klco JM, Ramu A, Lamprecht TL, Wagner AH, Campbell KM, Lesurf R, Hundal J, Zhang J, Spies NC, Ainscough BJ, Larson DE, Heath SE, Fronick C, O'Laughlin S, Fulton RS, Magrini V, McGrath S, Smith SM, Miller CA, Maher CA, Payton JE, Walker JR, Eldred JM, Walter MJ, Link DC, Graubert TA, Westervelt P, Kulkarni S, DiPersio JF, Mardis ER, Wilson RK, Ley TJ
    Exp Hematol 2016 Jul;44(7):603-13
  • Radioimmunotherapy-based conditioning for hematopoietic stem cell transplantation: Another step forward
    Ali AM, Dehdashti F, DiPersio JF, Cashen AF
    Blood Rev 2016 Sep;30(5):389-99
  • HLA disparity is not inconsequential in peripheral blood T-replete haploidentical hematopoietic stem cell transplantation
    Rashidi A, DiPersio JF, Westervelt P, Abboud CN, Schroeder MA, Pusic I, Cashen AF, Fehniger TA, Romee R
    Bone Marrow Transplant 2016 Sep;51(9):1275-8
  • Gold nanoclusters doped with 64Cu for CXCR4 positron emission tomography imaging of breast cancer and metastasis
    Zhao Y, Detering L, Sultan D, Cooper ML, You M, Cho S, Meier SL, Luehmann H, Sun G, Rettig M, Dehdashti F, Wooley KL, DiPersio JF, Liu Y
    ACS Nano 2016 Jun 28;10(6):5959-5970
  • The role of biomarkers in the diagnosis and risk stratification of acute graft-versus-host disease: a systematic review
    Ali AM, DiPersio JF, Schroeder MA
    Biol Blood Marrow Transplant 2016 Sep;22(9):1552-64
  • Intravenous busulfan-based myeloablative conditioning regimens prior to hematopoietic cell transplantation for hematologic malignancies
    Pasquini MC, Le-Rademacher J, Zhu X, Artz A, DiPersio J, Fernandez HF, Mineishi S, Kamishohara M, Mehta J, Nakamura Y, Ratanatharathorn V, Sobecks R, Burkart J, Bredeson C
    Biol Blood Marrow Transplant 2016 Aug;22(8):1424-1430
  • A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndrome
    Cherian MA, Tibes R, Gao F, Fletcher T, Fiala M, Uy GL, Westervelt P, Jacoby MA, Cashen AF, Stockerl-Goldstein K, DiPersio JF, Vij R
    Leuk Lymphoma 2016 Nov;57(11):2535-2540
  • High-throughput sequencing of cerebrospinal fluid for diagnosis of chronic Propionibacterium acnes meningitis in an allogeneic stem cell transplant recipient
    Wylie KM, Blanco-Guzman M, Wylie TN, Lawrence SJ, Ghobadi A, DiPersio JF, Storch GA
    Transpl Infect Dis 2016 Apr;18(2):227-33
  • Chemotherapy versus hypomethylating agents for the treatment of relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplant
    Motabi IH, Ghobadi A, Liu J, Schroeder M, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Uy GL, Vij R, Westervelt P, DiPersio JF
    Biol Blood Marrow Transplant 2016 Jul;22(7):1324-9
  • The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia
    Rashidi A, Wolach O, El-Jawahri A, Ho VT, DiPersio JF, Soiffer R, Stone RM, Chen YB
    Leuk Lymphoma 2016 Aug;57(8):1977-1979
  • Peritransplant serum albumin decline predicts subsequent severe acute graft-versus-host disease after mucotoxic myeloablative conditioning
    Rashidi A, DiPersio JF, Westervelt P, Abboud CN, Schroeder MA, Cashen AF, Pusic I, Romee R
    Biol Blood Marrow Transplant 2016 Jun;22(6):1137-41
  • Steroids versus steroids plus additional agent in frontline treatment of acute graft-versus-host disease: A systematic review and meta-analysis of randomized trials
    Rashidi A, DiPersio JF, Sandmaier BM, Colditz GA, Weisdorf DJ
    Biol Blood Marrow Transplant 2016 Jun;22(6):1133-7
  • Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidence
    Rashidi A, DiPersio JF
    Ther Adv Hematol 2016 Feb;7(1):40-51
  • Ex vivo and in vivo evaluation of overexpressed VLA-4 in multiple myeloma using LLP2A imaging agents
    Soodgupta D, Zhou H, Beaino W, Lu L, Rettig M, Snee M, Skeath J, DiPersio JF, Akers WJ, Laforest R, Anderson CJ, Tomasson MH, Shokeen M
    J Nucl Med 2016 Apr;57(4):640-5
  • Phase-1/-2 study of pomalidomide in chronic GvHD
    Pusic I, Rettig MP, DiPersio JF, Bauer S, McFarland K, Gale RP, Pavletic SZ
    Bone Marrow Transplant 2016 Apr;51(4):612-614
  • A phase I study of thymoglobulin for relapsed or refractory multiple myeloma
    Keller J, Fiala MA, DiPersio J, Stockerl-Goldstein K, Vij R, Heldermon CD
    Leuk Lymphoma 2016 Feb;57(2):453-5
  • Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML
    Wong TN, Miller CA, Klco JM, Petti A, Demeter R, Helton NM, Li T, Fulton RS, Heath SE, Mardis ER, Westervelt P, DiPersio JF, Walter MJ, Welch JS, Graubert TA, Wilson RK, Ley TJ, Link DC
    Blood 2016 Feb 18;127(7):893-7
  • The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy
    Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Vina M, Hartzman RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, Mueller CR, Perales MA, Setterholm M, Woolfrey AE, Yu N, Eapen M
    Blood 2016 Jan 14;127(2):260-7
  • Acute myeloid leukemia presenting with extensive bone marrow necrosis, leukemia cutis and testicular involvement: successful treatment with allogeneic hematopoietic stem cell transplantation
    Rashidi A, DiPersio JF, Westervelt P, Abboud CN, Romee R
    Bone Marrow Transplant 2016 Mar;51(3):454-5
  • Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform
    Al-Hussaini M, Rettig MP, Ritchey JK, Karpova D, Uy GL, Eissenberg LG, Gao F, Eades WC, Bonvini E, Chichili GR, Moore PA, Johnson S, Collins L, DiPersio JF
    Blood 2016 Jan 7;127(1):122-31
  • Outcomes of allogeneic stem cell transplantation in elderly patients with acute myeloid leukemia: a systematic review and meta-analysis
    Rashidi A, Ebadi M, Colditz GA, DiPersio JF
    Biol Blood Marrow Transplant 2016 Apr;22(4):651-7
  • A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia
    Wartman LD, Fiala MA, Fletcher T, Hawkins ER, Cashen A, DiPersio JF, Jacoby MA, Stockerl-Goldstein KE, Pusic I, Uy GL, Westervelt P, Vij R
    Leuk Lymphoma 2016 Mar;57(3):728-730
  • Patterns and functional implications of rare germline variants across 12 cancer types
    Lu C, Xie M, Wendl MC, Wang J, McLellan MD, Leiserson MD, Huang KL, Wyczalkowski MA, Jayasinghe R, Banerjee T, Ning J, Tripathi P, Zhang Q, Niu B, Ye K, Schmidt HK, Fulton RS, McMichael JF, Batra P, Kandoth C, Bharadwaj M, Koboldt DC, Miller CA, Kanchi KL, Eldred JM, Larson DE, Welch JS, You M, Ozenberger BA, Govindan R, Walter MJ, Ellis MJ, Mardis ER, Graubert TA, DiPersio JF, Ley TJ, Wilson RK, Goodfellow PJ, Raphael BJ, Chen F, Johnson KJ, Parvin JD, Ding L
    Nat Commun 2015 Dec 22;6:10086
  • Maintenance therapy with decitabine after allogeneic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome
    Pusic I, Choi J, Fiala MA, Gao F, Holt M, Cashen AF, Vij R, Abboud CN, Stockerl-Goldstein KE, Jacoby MA, Uy GL, Westervelt P, DiPersio JF
    Biol Blood Marrow Transplant 2015 Oct;21(10):1761-9
  • Diabetes limits stem cell mobilization following G-CSF but not plerixafor
    Fadini GP, Fiala M, Cappellari R, Danna M, Park S, Poncina N, Menegazzo L, Albiero M, DiPersio J, Stockerl-Goldstein K, Avogaro A
    Diabetes 2015 Aug;64(8):2969-77
  • Hematologic recovery after pretransplant chemotherapy does not influence survival after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients
    Vu K, Manjappa S, DiPersio JF, Gao F, Westervelt P, Vij R, Stockerl-Goldstein KE, Uy GL, Abboud CN, Schroeder MA, Fehniger TA, Cashen AF, Romee R
    Biol Blood Marrow Transplant 2015 Aug;21(8):1425-30
  • NCCN oncology research program's investigator steering committee and NCCN best practices committee molecular profiling surveys
    Kurzrock R, Colevas AD, Olszanski A, Akerley W, Arteaga CL, Carson WE 3rd, Clark JW, DiPersio JF, Ettinger DS, Morgan RJ Jr, Schwartzberg LS, Venook AP, Gocke CD, Tait J, Stewart FM
    J Natl Compr Canc Netw 2015 Nov;13(11):1337-46
  • Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia
    Churpek JE, Pyrtel K, Kanchi KL, Shao J, Koboldt D, Miller CA, Shen D, Fulton R, O'Laughlin M, Fronick C, Pusic I, Uy GL, Braunstein EM, Levis M, Ross J, Elliott K, Heath S, Jiang A, Westervelt P, DiPersio JF, Link DC, Walter MJ, Welch J, Wilson R, Ley TJ, Godley LA, Graubert TA
    Blood 2015 Nov 26;126(22):2484-90
  • Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia
    Uy GL, Hsu YM, Schmidt AP, Stock W, Fletcher TR, Trinkaus KM, Westervelt P, DiPersio JF, Link DC
    Leuk Res 2015 Dec;39(12):1437-42
  • Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia
    Klco JM, Miller CA, Griffith M, Petti A, Spencer DH, Ketkar-Kulkarni S, Wartman LD, Christopher M, Lamprecht TL, Helton NM, Duncavage EJ, Payton JE, Baty J, Heath SE, Griffith OL, Shen D, Hundal J, Chang GS, Fulton R, O'Laughlin M, Fronick C, Magrini V, Demeter RT, Larson DE, Kulkarni S, Ozenberger BA, Welch JS, Walter MJ, Graubert TA, Westervelt P, Radich JP, Link DC, Mardis ER, DiPersio JF, Wilson RK, Ley TJ
    JAMA 2015 Aug 25;314(8):811-822
  • GPR18 controls reconstitution of mouse small intestine intraepithelial lymphocytes following bone marrow transplantation
    Becker AM, Callahan DJ, Richner JM, Choi J, DiPersio JF, Diamond MS, Bhattacharya D
    PLoS One 2015 Jul 21;10(7):e0133854
  • Re: Disparities in utilization of autologous hematopoietic cell transplantation for treatment of multiple myeloma
    Fiala MA, Finney JD, Stockerl-Goldstein KE, Tomasson MH, DiPersio JF, Vij R, Wildes TM
    Biol Blood Marrow Transplant 2015 Jul;21(7):1153-4
  • Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia-results of a phase I dose-escalation study
    DiPersio JF, Erba HP, Larson RA, Luger SM, Tallman MS, Brill JM, Vuagniaux G, Rouits E, Sorensen JM, Zanna C
    Clin Lymphoma Myeloma Leuk 2015 Jul;15(7):443-9
  • [(18)F]FHBG PET/CT imaging of CD34-TK75 transduced donor T cells in relapsed allogeneic stem cell transplant patients: safety and feasibility
    Eissenberg LG, Rettig MP, Ritchey JK, Prior JL, Schwarz SW, Frye J, White BS, Fulton RS, Ghobadi A, Cooper ML, Couriel DR, Seegulam ME, Piwnica-Worms D, Dehdashti F, Cornetta K, DiPersio JF
    Mol Ther 2015 Jun;23(6):1110-22
  • Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I
    Verstovsek S, Mesa RA, Gotlib J, Levy RS, Gupta V, DiPersio JF, Catalano JV, Deininger MW, Miller CB, Silver RT, Talpaz M, Winton EF, Harvey JH Jr, Arcasoy MO, Hexner EO, Lyons RM, Raza A, Vaddi K, Sun W, Peng W, Sandor V, Kantarjian H
    Haematologica 2015 Apr;100(4):479-88
  • Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
    Wong TN, Ramsingh G, Young AL, Miller CA, Touma W, Welch JS, Lamprecht TL, Shen D, Hundal J, Fulton RS, Heath S, Baty JD, Klco JM, Ding L, Mardis ER, Westervelt P, DiPersio JF, Walter MJ, Graubert TA, Ley TJ, Druley TE, Link DC, Wilson RK
    Nature 2015 Feb 26;518(7540):552-555
  • Caspase-9 is required for normal hematopoietic development and protection from alkylator-induced DNA damage in mice
    Lu EP, McLellan M, Ding L, Fulton R, Mardis ER, Wilson RK, Miller CA, Westervelt P, DiPersio JF, Link DC, Walter MJ, Ley TJ, Graubert TA
    Blood 2014 Dec 18;124(26):3887-95
  • Age-related mutations associated with clonal hematopoietic expansion and malignancies
    Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl MC, McMichael JF, Schmidt HK, Yellapantula V, Miller CA, Ozenberger BA, Welch JS, Link DC, Walter MJ, Mardis ER, DiPersio JF, Chen F, Wilson RK, Ley TJ, Ding L
    Nat Med 2014 Dec;20(12):1472-1478
  • A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma
    Wang TF, Fiala MA, Cashen AF, Uy GL, Abboud CN, Fletcher T, Wu N, Westervelt P, DiPersio JF, Stockerl-Goldstein KE, Vij R
    Bone Marrow Transplant 2014 Nov;49(11):1366-70
  • Conservative management of pneumatosis intestinalis after allogeneic hematopoietic SCT
    Bhamidipati PK, Ghobadi A, Bauer S, DiPersio JF, Pusic I
    Bone Marrow Transplant 2014 Nov;49(11):1436-8
  • Suicide genes: monitoring cells in patients with a safety switch
    Eissenberg LG, Rettig M, Dehdashti F, Piwnica-Worms D, DiPersio JF
    Front Pharmacol 2014 Nov 6;5:241
  • Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect
    Choi J, Cooper ML, Alahmari B, Ritchey J, Collins L, Holt M, DiPersio JF
    PLoS One 2014 Oct 7;9(10):e109799
  • SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution
    Miller CA, White BS, Dees ND, Griffith M, Welch JS, Griffith OL, Vij R, Tomasson MH, Graubert TA, Walter MJ, Ellis MJ, Schierding W, DiPersio JF, Ley TJ, Mardis ER, Wilson RK, Ding L
    PLoS Comput Biol 2014 Aug 7;10(8):e1003665
  • Bortezomib is a rapid mobilizer of hematopoietic stem cells in mice via modulation of the VCAM-1/VLA-4 axis
    Ghobadi A, Rettig MP, Cooper ML, Holt MS, Ritchey JK, Eissenberg L, DiPersio JF
    Blood 2014 Oct 23;124(17):2752-4
  • A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML
    Welch JS, Niu H, Uy GL, Westervelt P, Abboud CN, Vij R, Stockerl-Goldstein KE, Jacoby M, Pusic I, Schroeder MA, DiPersio JF, Cashen AF
    Am J Hematol 2014 Aug;89(8):E103-8
  • Haploidentical transplantation using G-CSF-mobilized T-cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated with favorable outcomes
    Bhamidipati PK, DiPersio JF, Stockerl-Goldstein K, Rashidi A, Gao F, Uy GL, Westervelt P, Vij R, Schroeder MA, Abboud CN, Keller JW, Fehniger TA, Romee R
    Bone Marrow Transplant 2014 Aug;49(8):1124-6
  • Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic
    Al-Hussaini M, DiPersio JF
    Expert Rev Hematol 2014 Aug;7(4):439-64
  • CMV prophylaxis in hematopoietic-cell transplantation
    Romee R, DiPersio JF
    N Engl J Med 2014 Aug 7;371(6):576
  • Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing
    Hughes AE, Magrini V, Demeter R, Miller CA, Fulton R, Fulton LL, Eades WC, Elliott K, Heath S, Westervelt P, Ding L, Conrad DF, White BS, Shao J, Link DC, DiPersio JF, Mardis ER, Wilson RK, Ley TJ, Walter MJ, Graubert TA
    PLoS Genet 2014 Jul 10;10(7):e1004462
  • Reconsideration of age as a contraindication for curative therapy of sickle cell disease
    King AA, DiPersio JF
    JAMA 2014 Jul 2;312(1):33-4
  • Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia
    Jacoby MA, Martin MG, Uy GL, Westervelt P, DiPersio JF, Cashen A, Stockerl-Goldstein K, Vij R, Luo J, Reineck T, Bernabe N, Abboud CN
    Am J Hematol 2014 May;89(5):487-92
  • Effect of epigallocatechin-3-gallate on graft-versus-host disease
    Choi J, Cooper ML, Ziga ED, Ritchey J, DiPersio JF
    Cell Transplant 2014;23(9):1163-6
  • Genomic tools in acute myeloid leukemia: from the bench to the bedside
    White BS, DiPersio JF
    Cancer 2014 Apr 15;120(8):1134-44
  • Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4
    Liu H, Westergard TD, Cashen A, Piwnica-Worms DR, Kunkle L, Vij R, Pham CG, DiPersio J, Cheng EH, Hsieh JJ
    Cancer Cell 2014 Apr 14;25(4):530-42
  • Functional heterogeneity of genetically defined subclones in acute myeloid leukemia
    Klco JM, Spencer DH, Miller CA, Griffith M, Lamprecht TL, O'Laughlin M, Fronick C, Magrini V, Demeter RT, Fulton RS, Eades WC, Link DC, Graubert TA, Walter MJ, Mardis ER, DiPersio JF, Wilson RK, Ley TJ
    Cancer Cell 2014 Mar 17;25(3):379-92
  • Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations
    Giralt S, Costa L, Schriber J, DiPersio J, Maziarz R, McCarty J, Shaughnessy P, Snyder E, Bensinger W, Copelan E, Hosing C, Negrin R, Petersen FB, Rondelli D, Soiffer R, Leather H, Pazzalia A, Devine S
    Biol Blood Marrow Transplant 2014 Mar;20(3):295-308
  • Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML
    Ramsingh G, Westervelt P, McBride A, Stockerl-Goldstein K, Vij R, Fiala M, Uy G, Cashen A, DiPersio JF, Abboud CN
    Int J Hematol 2014 Mar;99(3):272-8
  • Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies
    Mesa RA, Kiladjian JJ, Verstovsek S, Al-Ali HK, Gotlib J, Gisslinger H, Levy R, Siulnik A, Gupta V, Khan M, DiPersio JF, McQuitty M, Catalano JV, Hunter DS, Knoops L, Deininger M, Cervantes F, Miller C, Vannucchi AM, Silver RT, Barbui T, Talpaz M, Barosi G, Winton EF, Mendeson E, Harvey JH Jr, Arcasoy MO, Hexner E, Lyons RM, Paquette R, Raza A, Sun W, Sandor V, Kantarjian HM, Harrison C
    Haematologica 2014 Feb;99(2):292-8
  • Advances in stem cell mobilization
    Hopman RK, DiPersio JF
    Blood Rev 2014 Jan;28(1):31-40
  • Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial
    Choi SW, Braun T, Chang L, Ferrara JL, Pawarode A, Magenau JM, Hou G, Beumer JH, Levine JE, Goldstein S, Couriel DR, Stockerl-Goldstein K, Krijanovski OI, Kitko C, Yanik GA, Lehmann MH, Tawara I, Sun Y, Paczesny S, Mapara MY, Dinarello CA, DiPersio JF, Reddy P
    Lancet Oncol 2014 Jan;15(1):87-95
  • Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen
    Manjappa S, Bhamidipati PK, Stokerl-Goldstein KE, DiPersio JF, Uy GL, Westervelt P, Liu J, Schroeder MA, Vij R, Abboud CN, Fehniger TA, Cashen AF, Pusic I, Jacoby M, Meera SJ, Romee R
    Biol Blood Marrow Transplant 2014 Jan;20(1):46-52
  • Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation
    Bredeson C, Lerademacher J, Kato K, DiPersio JF, Agura E, Devine SM, Appelbaum FR, Tomblyn MR, Laport GG, Zhu X, McCarthy PL, Ho VT, Cooke KR, Armstrong E, Smith A, Rizzo JD, Burkart JM, Pasquini MC
    Blood 2013 Dec 5;122(24):3871-8
  • A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias
    Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DiPersio J, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Muller MC, Gambacorti-Passerini C, Wong S, Lustgarten S, Rivera VM, Clackson T, Turner CD, Haluska FG, Guilhot F, Deininger MW, Hochhaus A, Hughes T, Goldman JM, Shah NP, Kantarjian H, Hughes T, Schwarer A, MacCallum P, Seymour J, Arthur C, Mills A, Knoops L, Verhoef G, Assouline S, Lipton JH, Forrest D, Bence-Bruckler I, Laneuville P, Etienne G, Rousselot P, Coiteux V, Rea D, Nicolini F, Guilhot F, Legros L, Huguet- Rigal F, Guerci-Bresler AP, le Coutre P, Ottmann OG, Hochhaus A, Muller MC, von Bubnoff N, Baccarani M, Rosti G, Marasca R, Gambacorti C, Saglio G, Abruzzese E, Kim DW, Chuah C, Cervantes F, de Paz Arias R, Sanchez-Guijo FM, Hernandez-Boluda JC, Ekblom M, Stenke L, Olsson-Stromberg U, Ossenkoppele G, Daenen SM, Holyoake T, Clark RE, Apperley J, O'Brien SG, Byrne J, Talpaz M, Khoury HJ, Baer MR, DeAngelo DJ, Wetzler M, Altman JK, Larson RA, Schiffer CA, Moore JO, Goldberg S, Cortes JE, Midathada M, Paquette R, Emmons RV, Kropf PL, Mauro M, Berman E, Roboz G, DiPersio J, Deininger MW, Oehler VG, Pinilla-Ibarz J, Baccarani M, Cortes J, Deininger M, Goldman J, Guilhot F, Hochhaus A, Hughes T, Shah N, Talpaz M
    N Engl J Med 2013 Nov 7;369(19):1783-96
  • Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34(+) hematopoietic progenitor cells in patients >/=60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma
    Micallef IN, Stiff PJ, Stadtmauer EA, Bolwell BJ, Nademanee AP, Maziarz RT, Partisano AM, Marulkar S, DiPersio JF
    Am J Hematol 2013 Dec;88(12):1017-23
  • Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
    Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A, Hoadley K, Triche TJ Jr, Laird PW, Baty JD, Fulton LL, Fulton R, Heath SE, Kalicki-Veizer J, Kandoth C, Klco JM, Koboldt DC, Kanchi KL, Kulkarni S, Lamprecht TL, Larson DE, Lin L, Lu C, McLellan MD, McMichael JF, Payton J, Schmidt H, Spencer DH, Tomasson MH, Wallis JW, Wartman LD, Watson MA, Welch J, Wendl MC, Ally A, Balasundaram M, Birol I, Butterfield Y, Chiu R, Chu A, Chuah E, Chun HJ, Corbett R, Dhalla N, Guin R, He A, Hirst C, Hirst M, Holt RA, Jones S, Karsan A, Lee D, Li HI, Marra MA, Mayo M, Moore RA, Mungall K, Parker J, Pleasance E, Plettner P, Schein J, Stoll D, Swanson L, Tam A, Thiessen N, Varhol R, Wye N, Zhao Y, Gabriel S, Getz G, Sougnez C, Zou L, Leiserson MD, Vandin F, Wu HT, Applebaum F, Baylin SB, Akbani R, Broom BM, Chen K, Motter TC, Nguyen K, Weinstein JN, Zhang N, Ferguson ML, Adams C, Black A, Bowen J, Gastier-Foster J, Grossman T, Lichtenberg T, Wise L, Davidsen T, Demchok JA, Shaw KR, Sheth M, Sofia HJ, Yang L, Downing JR, Eley G, Alonso S, Ayala B, Baboud J, Backus M, Barletta SP, Berton DL, Chu AL, Girshik S, Jensen MA, Kahn A, Kothiyal P, Nicholls MC, Pihl TD, Pot DA, Raman R, Sanbhadti RN, Snyder EE, Srinivasan D, Walton J, Wan Y, Wang Z, Issa JP, Le Beau M, Carroll M, Kantarjian H, Kornblau S, Bootwalla MS, Lai PH, Shen H, Van Den Berg DJ, Weisenberger DJ, Link DC, Walter MJ, Ozenberger BA, Mardis ER, Westervelt P, Graubert TA, DiPersio JF, Wilson RK
    N Engl J Med 2013 May 30;368(22):2059-74
  • The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, phase III study in patients with myelofibrosis
    Verstovsek S, Mesa RA, Gotlib J, Levy RS, Gupta V, DiPersio JF, Catalano JV, Deininger M, Miller C, Silver RT, Talpaz M, Winton EF, Harvey JH Jr, Arcasoy MO, Hexner E, Lyons RM, Paquette R, Raza A, Vaddi K, Erickson-Viitanen S, Sun W, Sandor V, Kantarjian HM
    Br J Haematol 2013 May;161(4):508-16
  • Dual receptor T cells mediate pathologic alloreactivity in patients with acute graft-versus-host disease
    Morris GP, Uy GL, Donermeyer D, DiPersio JF, Allen PM
    Sci Transl Med 2013 Jun 5;5(188):188ra74
  • Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis
    Koreth J, Pidala J, Perez WS, Deeg HJ, Garcia-Manero G, Malcovati L, Cazzola M, Park S, Itzykson R, Ades L, Fenaux P, Jadersten M, Hellstrom-Lindberg E, Gale RP, Beach CL, Lee SJ, Horowitz MM, Greenberg PL, Tallman MS, DiPersio JF, Bunjes D, Weisdorf DJ, Cutler C
    J Clin Oncol 2013 Jul 20;31(21):2662-70
  • Plerixafor plus granulocyte colony-stimulating factor improves the mobilization of hematopoietic stem cells in patients with non-Hodgkin lymphoma and low circulating peripheral blood CD34(+) cells
    Maziarz RT, Nademanee AP, Micallef IN, Stiff PJ, Calandra G, Angell J, DiPersio JF, Bolwell BJ
    Biol Blood Marrow Transplant 2013 Apr;19(4):670-5
  • Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
    Walter MJ, Shen D, Shao J, Ding L, White BS, Kandoth C, Miller CA, Niu B, McLellan MD, Dees ND, Fulton R, Elliot K, Heath S, Grillot M, Westervelt P, Link DC, DiPersio JF, Mardis E, Ley TJ, Wilson RK, Graubert TA
    Leukemia 2013 Jun;27(6):1275-82
  • A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML
    Ramsingh G, Westervelt P, Cashen AF, Uy GL, Stockerl-Goldstein K, Abboud CN, Bernabe N, Monahan R, DiPersio JF, Vij R
    Leukemia 2013 Mar;27(3):725-8
  • Advances in stem cell mobilization
    Motabi IH, DiPersio JF
    Blood Rev 2012 Nov;26(6):267-78
  • Preclinical evaluation of Mab CC188 for ovarian cancer imaging
    Xu M, Rettig MP, Sudlow G, Wang B, Akers WJ, Cao D, Mutch DG, DiPersio JF, Achilefu S
    Int J Cancer 2012 Sep 15;131(6):1351-9
  • Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial
    Nademanee AP, DiPersio JF, Maziarz RT, Stadtmauer EA, Micallef IN, Stiff PJ, Hsu FJ, Bridger G, Bolwell BJ
    Biol Blood Marrow Transplant 2012 Oct;18(10):1564-72
  • IFNgammaR signaling mediates alloreactive T-cell trafficking and GVHD
    Choi J, Ziga ED, Ritchey J, Collins L, Prior JL, Cooper ML, Piwnica-Worms D, DiPersio JF
    Blood 2012 Nov 8;120(19):4093-103
  • Resequencing analysis of the candidate tyrosine kinase and RAS pathway gene families in multiple myeloma
    Hucthagowder V, Meyer R, Mullins C, Nagarajan R, DiPersio JF, Vij R, Tomasson MH, Kulkarni S
    Cancer Genet 2012 Sep;205(9):474-8
  • The origin and evolution of mutations in acute myeloid leukemia
    Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC, Wartman LD, Lamprecht TL, Liu F, Xia J, Kandoth C, Fulton RS, McLellan MD, Dooling DJ, Wallis JW, Chen K, Harris CC, Schmidt HK, Kalicki-Veizer JM, Lu C, Zhang Q, Lin L, O'Laughlin MD, McMichael JF, Delehaunty KD, Fulton LA, Magrini VJ, McGrath SD, Demeter RT, Vickery TL, Hundal J, Cook LL, Swift GW, Reed JP, Alldredge PA, Wylie TN, Walker JR, Watson MA, Heath SE, Shannon WD, Varghese N, Nagarajan R, Payton JE, Baty JD, Kulkarni S, Klco JM, Tomasson MH, Westervelt P, Walter MJ, Graubert TA, DiPersio JF, Ding L, Mardis ER, Wilson RK
    Cell 2012 Jul 20;150(2):264-78
  • Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis
    Macanas-Pirard P, Leisewitz A, Broekhuizen R, Cautivo K, Barriga FM, Leisewitz F, Gidi V, Riquelme E, Montecinos VP, Swett P, Besa P, Ramirez P, Ocqueteau M, Kalergis AM, Holt M, Rettig M, DiPersio JF, Nervi B
    PLoS One 2012;7(5):e37203
  • Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (04-0274) and review of the literature
    Chawla JS, Ghobadi A, Mosley J 3rd, Verkruyse L, Trinkaus K, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Uy GL, Westervelt P, DiPersio JF, Vij R
    Transpl Infect Dis 2012 Jun;14(3):259-67
  • Clonal architecture of secondary acute myeloid leukemia
    Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K, Larson DE, McLellan MD, Dooling D, Abbott R, Fulton R, Magrini V, Schmidt H, Kalicki-Veizer J, O'Laughlin M, Fan X, Grillot M, Witowski S, Heath S, Frater JL, Eades W, Tomasson M, Westervelt P, DiPersio JF, Link DC, Mardis ER, Ley TJ, Wilson RK, Graubert TA
    N Engl J Med 2012 Mar 22;366(12):1090-8
  • A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
    Uy GL, Rettig MP, Motabi IH, McFarland K, Trinkaus KM, Hladnik LM, Kulkarni S, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Vij R, Westervelt P, DiPersio JF
    Blood 2012 Apr 26;119(17):3917-24
  • Economic evaluation of plerixafor for stem cell mobilization
    Kymes SM, Pusic I, Lambert DL, Gregory M, Carson KR, DiPersio JF
    Am J Manag Care 2012 Jan;18(1):33-41
  • A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis
    Verstovsek S, Mesa RA, Gotlib J, Levy RS, Gupta V, DiPersio JF, Catalano JV, Deininger M, Miller C, Silver RT, Talpaz M, Winton EF, Harvey JH Jr, Arcasoy MO, Hexner E, Lyons RM, Paquette R, Raza A, Vaddi K, Erickson-Viitanen S, Koumenis IL, Sun W, Sandor V, Kantarjian HM
    N Engl J Med 2012 Mar;366(9):799-807
  • Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia
    Cortes J, Kantarjian H, Ball ED, DiPersio J, Kolitz JE, Fernandez HF, Goodman M, Borthakur G, Baer MR, Wetzler M
    Cancer 2012 Jan 15;118(2):418-27
  • New hope for mobilization failures . . . again
    DiPersio JF
    Biol Blood Marrow Transplant 2012 Feb;18(2):159-60
  • Mobilization of hematopoietic stem and leukemia cells
    Schroeder MA, DiPersio JF
    J Leukoc Biol 2012 Jan;91(1):47-57
  • T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome
    Weisdorf D, Cooley S, Devine S, Fehniger TA, DiPersio J, Anasetti C, Waller EK, Porter D, Farag S, Drobyski W, Defor T, Haagenson M, Curtsinger J, Miller J
    Biol Blood Marrow Transplant 2012 Jun;18(6):937-43
  • Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS)
    Cashen A, Juckett M, Jumonville A, Litzow M, Flynn PJ, Eckardt J, Laplant B, Laumann K, Erlichman C, DiPersio J
    Ann Hematol 2012 Jan;91(1):33-8
  • Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4
    Rettig MP, Ansstas G, DiPersio JF
    Leukemia 2012 Jan;26(1):34-53
  • Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice
    Juarez JG, Harun N, Thien M, Welschinger R, Baraz R, Dela Pena A, Pitson SM, Rettig M, DiPersio JF, Bradstock KF, Bendall LJ
    Blood 2012 Jan 19;119(3):707-16
  • Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
    Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD, McMichael JF, Wallis JW, Lu C, Shen D, Harris CC, Dooling DJ, Fulton RS, Fulton LL, Chen K, Schmidt H, Kalicki-Veizer J, Magrini VJ, Cook L, McGrath SD, Vickery TL, Wendl MC, Heath S, Watson MA, Link DC, Tomasson MH, Shannon WD, Payton JE, Kulkarni S, Westervelt P, Walter MJ, Graubert TA, Mardis ER, Wilson RK, DiPersio JF
    Nature 2012 Jan 11;481(7382):506-10
  • Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation
    Smeltzer JP, Cashen AF, Zhang Q, Homb A, Dehdashti F, Abboud CN, DiPersio JF, Stockerl-Goldstein KE, Uy GL, Vij R, Westervelt P, Bartlett NL, Fehniger TA
    Biol Blood Marrow Transplant 2011 Nov;17(11):1646-52
  • Diabetic stem-cell "mobilopathy"
    DiPersio JF
    N Engl J Med 2011 Dec 29;365(26):2536-8
  • Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
    Graubert TA, Shen D, Ding L, Okeyo-Owuor T, Lunn CL, Shao J, Krysiak K, Harris CC, Koboldt DC, Larson DE, McLellan MD, Dooling DJ, Abbott RM, Fulton RS, Schmidt H, Kalicki-Veizer J, O'Laughlin M, Grillot M, Baty J, Heath S, Frater JL, Nasim T, Link DC, Tomasson MH, Westervelt P, DiPersio JF, Mardis ER, Ley TJ, Wilson RK, Walter MJ
    Nat Genet 2011 Dec 11;44(1):53-7
  • Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
    Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M, Fulton R, Schmidt H, Kalicki-Veizer J, O'Laughlin M, Kandoth C, Baty J, Westervelt P, DiPersio JF, Mardis ER, Wilson RK, Ley TJ, Graubert TA
    Leukemia 2011 Jul;25(7):1153-8
  • Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study
    Welch JS, Klco JM, Gao F, Procknow E, Uy GL, Stockerl-Goldstein KE, Abboud CN, Westervelt P, DiPersio JF, Hassan A, Cashen AF, Vij R
    Am J Hematol 2011 Sep;86(9):796-800
  • Use of whole-genome sequencing to diagnose a cryptic fusion oncogene
    Welch JS, Westervelt P, Ding L, Larson DE, Klco JM, Kulkarni S, Wallis J, Chen K, Payton JE, Fulton RS, Veizer J, Schmidt H, Vickery TL, Heath S, Watson MA, Tomasson MH, Link DC, Graubert TA, DiPersio JF, Mardis ER, Ley TJ, Wilson RK
    JAMA 2011 Apr 20;305(15):1577-1584
  • Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission
    Farag SS, Maharry K, Zhang MJ, Perez WS, George SL, Mrozek K, DiPersio J, Bunjes DW, Marcucci G, Baer MR, Cairo M, Copelan E, Cutler CS, Isola L, Lazarus HM, Litzow MR, Marks DI, Ringden O, Rizzieri DA, Soiffer R, Larson RA, Tallman MS, Bloomfield CD, Weisdorf DJ
    Biol Blood Marrow Transplant 2011 Dec;17(12):1796-803
  • From trees to the forest: genes to genomics
    Mullighan C, Petersdorf E, Davies SM, DiPersio J
    Biol Blood Marrow Transplant 2011 Jan;17(1 Suppl):S52-7
  • A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
    Fehniger TA, Uy GL, Trinkaus K, Nelson AD, Demland J, Abboud CN, Cashen AF, Stockerl-Goldstein KE, Westervelt P, DiPersio JF, Vij R
    Blood 2011 Feb 10;117(6):1828-33
  • Relevance and clinical implications of tumor cell mobilization in the autologous transplant setting
    DiPersio JF, Ho AD, Hanrahan J, Hsu FJ, Fruehauf S
    Biol Blood Marrow Transplant 2011 Jul;17(7):943-55
  • Mouse models of graft-versus-host disease: advances and limitations
    Schroeder MA, DiPersio JF
    Dis Model Mech 2011 May-Jun;4(3):318-33
  • Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma
    Stiff PJ, Micallef I, Nademanee AP, Stadtmauer EA, Maziarz RT, Bolwell BJ, Bridger G, Marulkar S, Hsu FJ, DiPersio JF
    Biol Blood Marrow Transplant 2011 Aug;17(8):1146-53
  • Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
    Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Baden LR, Gersten ID, Mendizabal AM, Leather HL, Confer DL, Maziarz RT, Stadtmauer EA, Bolanos-Meade J, Brown J, DiPersio JF, Boeckh M, Marr KA
    Blood 2010 Dec 9;116(24):5111-8
  • DNMT3A mutations in acute myeloid leukemia
    Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, Larson DE, Kandoth C, Payton JE, Baty J, Welch J, Harris CC, Lichti CF, Townsend RR, Fulton RS, Dooling DJ, Koboldt DC, Schmidt H, Zhang Q, Osborne JR, Lin L, O'Laughlin M, McMichael JF, Delehaunty KD, McGrath SD, Fulton LA, Magrini VJ, Vickery TL, Hundal J, Cook LL, Conyers JJ, Swift GW, Reed JP, Alldredge PA, Wylie T, Walker J, Kalicki J, Watson MA, Heath S, Shannon WD, Varghese N, Nagarajan R, Westervelt P, Tomasson MH, Link DC, Graubert TA, DiPersio JF, Mardis ER, Wilson RK
    N Engl J Med 2010 Dec 16;363(25):2424-33
  • Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis
    Gupta V, Tallman MS, He W, Logan BR, Copelan E, Gale RP, Khoury HJ, Klumpp T, Koreth J, Lazarus HM, Marks DI, Martino R, Rizzieri DA, Rowe JM, Sabloff M, Waller EK, DiPersio JF, Bunjes DW, Weisdorf DJ
    Blood 2010 Sep 16;116(11):1839-1848
  • Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia
    Cashen AF, Schiller GJ, O'Donnell MR, DiPersio JF
    J Clin Oncol 2010 Feb 1;28(4):556-61
  • Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells
    Pusic I, DiPersio JF
    Curr Opin Hematol 2010 Jul;17(4):319-26
  • In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia
    Choi J, Ritchey J, Prior JL, Holt M, Shannon WD, Deych E, Piwnica-Worms DR, DiPersio JF
    Blood 2010 Jul 8;116(1):129-39
  • Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia
    Litzow MR, Tarima S, Perez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, DiPersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ
    Blood 2010 Mar 4;115(9):1850-7
  • Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome
    McClune BL, Weisdorf DJ, Pedersen TL, Tunes da Silva G, Tallman MS, Sierra J, DiPersio J, Keating A, Gale RP, George B, Gupta V, Hahn T, Isola L, Jagasia M, Lazarus H, Marks D, Maziarz R, Waller EK, Bredeson C, Giralt S
    J Clin Oncol 2010 Apr 10;28(11):1878-87
  • Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes
    Dubberke ER, Reske KA, Srivastava A, Sadhu J, Gatti R, Young RM, Rakes LC, Dieckgraefe B, DiPersio J, Fraser VJ
    Clin Transplant 2010 Mar 1;24(2):192-8
  • Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
    Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Baden LR, Gersten ID, Mendizabal AM, Leather HL, Confer DL, Maziarz RT, Stadtmauer EA, Bolanos-Meade J, Brown J, DiPersio JF, Boeckh M, Marr KA
    Blood 2010 Dec 9;116(24):5111-5118
  • Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI
    Druley TE, Hayashi R, Mansur DB, Zhang QJ, Barnes Y, Trinkaus K, Witty S, Thomas T, Klein EE, DiPersio JF, Adkins D, Shenoy S
    Bone Marrow Transplant 2009 Feb;43(4):307-14
  • Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study
    Uy GL, Goyal SD, Fisher NM, Oza AY, Tomasson MH, Stockerl-Goldstein K, DiPersio JF, Vij R
    Bone Marrow Transplant 2009 May;43(10):793-800
  • Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
    Nervi B, Ramirez P, Rettig MP, Uy GL, Holt MS, Ritchey JK, Prior JL, Piwnica-Worms D, Bridger G, Ley TJ, DiPersio JF
    Blood 2009 Jun 11;113(24):6206-14
  • Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors
    Martin MG, DiPersio JF, Uy GL
    Leuk Lymphoma 2009 Jan;50(1):14-23
  • Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG
    Martin MG, Uy GL, Procknow E, Stockerl-Goldstein K, Cashen A, Westervelt P, Abboud CN, Augustin K, Luo J, DiPersio JF, Vij R
    Bone Marrow Transplant 2009 Jul;44(1):13-7
  • Dasatinib in relapsed or plateau-phase multiple myeloma
    Wildes TM, Procknow E, Gao F, DiPersio JF, Vij R
    Leuk Lymphoma 2009 Jan;50(1):137-40
  • Plerixafor
    DiPersio JF, Uy GL, Yasothan U, Kirkpatrick P
    Nat Rev Drug Discov 2009 Feb;8(2):105-6
  • Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma
    DiPersio JF, Stadtmauer EA, Nademanee A, Micallef IN, Stiff PJ, Kaufman JL, Maziarz RT, Hosing C, Fruehauf S, Horwitz M, Cooper D, Bridger G, Calandra G
    Blood 2009 Jun 4;113(23):5720-6
  • Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up
    Kantarjian H, Cortes J, Kim DW, Dorlhiac-Llacer P, Pasquini R, DiPersio J, Muller MC, Radich JP, Khoury HJ, Khoroshko N, Bradley-Garelik MB, Zhu C, Tallman MS
    Blood 2009 Jun 18;113(25):6322-9
  • BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells
    Ramirez P, Rettig MP, Uy GL, Deych E, Holt MS, Ritchey JK, DiPersio JF
    Blood 2009 Aug 13;114(7):1340-3
  • Advances in mobilization for the optimization of autologous stem cell transplantation
    Vose JM, Ho AD, Coiffier B, Corradini P, Khouri I, Sureda A, Van Besien K, DiPersio J
    Leuk Lymphoma 2009;50(9):1412-1421
  • A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes
    Martin MG, Walgren RA, Procknow E, Uy GL, Stockerl-Goldstein K, Cashen AF, Westervelt P, Abboud CN, Kreisel F, Augustin K, DiPersio JF, Vij R
    Am J Hematol 2009 Sep;84(9):560-4
  • Acquired copy number alterations in adult acute myeloid leukemia genomes
    Walter MJ, Payton JE, Ries RE, Shannon WD, Deshmukh H, Zhao Y, Baty J, Heath S, Westervelt P, Watson MA, Tomasson MH, Nagarajan R, O'Gara BP, Bloomfield CD, Mrozek K, Selzer RR, Richmond TA, Kitzman J, Geoghegan J, Eis PS, Maupin R, Fulton RS, McLellan M, Wilson RK, Mardis ER, Link DC, Graubert TA, DiPersio JF, Ley TJ
    Proc Natl Acad Sci U S A 2009 Aug 4;106(31):12950-5
  • Recurring mutations found by sequencing an acute myeloid leukemia genome
    Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath SD, Fulton LA, Locke DP, Magrini VJ, Abbott RM, Vickery TL, Reed JS, Robinson JS, Wylie T, Smith SM, Carmichael L, Eldred JM, Harris CC, Walker J, Peck JB, Du F, Dukes AF, Sanderson GE, Brummett AM, Clark E, McMichael JF, Meyer RJ, Schindler JK, Pohl CS, Wallis JW, Shi X, Lin L, Schmidt H, Tang Y, Haipek C, Wiechert ME, Ivy JV, Kalicki J, Elliott G, Ries RE, Payton JE, Westervelt P, Tomasson MH, Watson MA, Baty J, Heath S, Shannon WD, Nagarajan R, Link DC, Walter MJ, Graubert TA, DiPersio JF, Wilson RK, Ley TJ
    N Engl J Med 2009 Sep 10;361(11):1058-66
  • Cladribine in the treatment of acute myeloid leukemia: a single-institution experience
    Martin MG, Welch JS, Augustin K, Hladnik L, DiPersio JF, Abboud CN
    Clin Lymphoma Myeloma 2009 Aug;9(4):298-301
  • Optimal mobilization of normal and leukemic stem cells via modulation of chemokine and integrin axes
    Schroeder M, Rettig M, Ramirez P, DiPersio J
    AACR Educational Book, 2009
  • Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma
    DiPersio JF, Micallef IN, Stiff PJ, Bolwell BJ, Maziarz RT, Jacobsen E, Nademanee A, McCarty J, Bridger G, Calandra G
    J Clin Oncol 2009 Oct 1;27(28):4767-73
  • A phase 2 study of vorinostat in acute myeloid leukemia
    Schaefer EW, Loaiza-Bonilla A, Juckett M, DiPersio JF, Roy V, Slack J, Wu W, Laumann K, Espinoza-Delgado I, Gore SD
    Haematologica 2009 Oct;94(10):1375-82
  • Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF
    Martin MG, Augustin KM, Uy GL, Welch JS, Hladnik L, Goyal S, Tiwari D, Monahan RS, Reichley RM, Cashen AF, Stockerl-Goldstein K, Westervelt P, Abboud CN, DiPersio JF, Vij R
    Am J Hematol 2009 Nov;84(11):733-7
  • Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocol
    Micallef IN, Stiff PJ, DiPersio JF, Maziarz RT, McCarty JM, Bridger G, Calandra G
    Biol Blood Marrow Transplant 2009 Dec;15(12):1578-86
  • Next-generation sequencing of cancer genomes: back to the future
    Walter MJ, Graubert TA, DiPersio JF, Mardis ER, Wilson RK, Ley TJ
    Per Med 2009 Nov 1;6(6):653
  • Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors
    Martin MG, DiPersio JF, Uy GL
    Leuk Lymphoma 2009 Jan;50(1):14-23
  • Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)
    Cashen AF, Shah AK, Todt L, Fisher N, DiPersio J
    Cancer Chemother Pharmacol 2008 Apr;61(5):759-66
  • Emergence of Candida tropicalis resistant to caspofungin
    Pasquale T, Tomada JR, Ghannoun M, DiPersio J, Bonilla H
    J Antimicrob Chemother 2008 Jan;61(1):219
  • Identification of somatic JAK1 mutations in patients with acute myeloid leukemia
    Xiang Z, Zhao Y, Mitaksov V, Fremont DH, Kasai Y, Molitoris A, Ries RE, Miner TL, McLellan MD, DiPersio JF, Link DC, Payton JE, Graubert TA, Watson M, Shannon W, Heath SE, Nagarajan R, Mardis ER, Wilson RK, Ley TJ, Tomasson MH
    Blood 2008 May 1;111(9):4809-12
  • Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia
    Tomasson MH, Xiang Z, Walgren R, Zhao Y, Kasai Y, Miner T, Ries RE, Lubman O, Fremont D, McLellan MD, Payton JE, Westervelt P, DiPersio JF, Link DC, Walter MJ, Graubert TA, Watson M, Baty J, Heath S, Shannon WD, Nagarajan R, Bloomfield CD, Mardis ER, Wilson RK, Ley TJ
    Blood 2008 May 1;111(9):4797-808
  • First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States
    Mendes RE, Deshpande LM, Castanheira M, DiPersio J, Saubolle MA, Jones RN
    Antimicrob Agents Chemother 2008 Jun;52(6):2244-6
  • Rapid mobilization of functional donor hematopoietic cells without G-CSF using plerixafor, an antagonist of the CXCR4/SDF-1 interaction
    Devine SM, Vij R, Rettig M, Todt L, McGlauchlen K, Fisher N, Devine H, Link DC, Calandra G, Bridger G, Westervelt P, DiPersio JF
    Blood 2008 Aug 15;112(4):990-8
  • A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies
    Rizzieri DA, Feldman E, DiPersio JF, Gabrail N, Stock W, Strair R, Rivera VM, Albitar M, Bedrosian CL, Giles FJ
    Clin Cancer Res 2008 May 1;14(9):2756-62
  • Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma
    Wildes TM, Augustin KM, Sempek D, Zhang QJ, Vij R, DiPersio JF, Devine SM
    Biol Blood Marrow Transplant 2008 Jul;14(7):840-6
  • The use of growth factors in hematopoietic stem cell transplantation
    Pusic I, DiPersio JF
    Curr Pharm Des 2008;14(20):1950-61
  • Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation
    Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF, Westervelt P, Vij R, Abboud CN, Stockerl-Goldstein KE, Sempek DS, Smith AL, DiPersio JF
    Biol Blood Marrow Transplant 2008 Sep;14(9):1045-56
  • Total body irradiation before an allogeneic stem cell transplantation: is there a magic dose?
    Adkins DR, DiPersio JF
    Curr Opin Hematol 2008 Nov;15(6):555-60
  • A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma
    Cashen A, Lopez S, Gao F, Calandra G, MacFarland R, Badel K, DiPersio J
    Biol Blood Marrow Transplant 2008 Nov;14(11):1253-61
  • DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
    Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, Dooling D, Dunford-Shore BH, McGrath S, Hickenbotham M, Cook L, Abbott R, Larson DE, Koboldt DC, Pohl C, Smith S, Hawkins A, Abbott S, Locke D, Hillier LW, Miner T, Fulton L, Magrini V, Wylie T, Glasscock J, Conyers J, Sander N, Shi X, Osborne JR, Minx P, Gordon D, Chinwalla A, Zhao Y, Ries RE, Payton JE, Westervelt P, Tomasson MH, Watson M, Baty J, Ivanovich J, Heath S, Shannon WD, Nagarajan R, Walter MJ, Link DC, Graubert TA, DiPersio JF, Wilson RK
    Nature 2008 Nov 6;456(7218):66-72
  • Commonly dysregulated genes in murine APL cells
    Yuan W, Payton JE, Holt MS, Link DC, Watson MA, DiPersio JF, Ley TJ
    Blood 2007 Feb 1;109(3):961-70
  • A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease
    Macmillan ML, Couriel D, Weisdorf DJ, Schwab G, Havrilla N, Fleming TR, Huang S, Roskos L, Slavin S, Shadduck RK, DiPersio J, Territo M, Pavletic S, Linker C, Heslop HE, Joachim Deeg H, Blazar BR
    Blood 2007 Mar 15;109(6):2657-62
  • Reply to Jaber et al
    Dubberke ER, Sadhu J, Gatti R, Reske KA, DiPersio JF, Devine SM, Fraser VJ
    Infect Control Hosp Epidemiol 2008 Feb;29(2):189-190
  • Severity of Clostridium difficile-Associated Disease (CDAD) in Allogeneic Stem Cell Transplant Recipients: Evaluation of a CDAD Severity Grading System
    Dubberke ER, Sadhu J, Gatti R, Reske KA, DiPersio JF, Devine SM, Fraser VJ
    Infect Control Hosp Epidemiol 2007 Feb;28(2):208-11
  • AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent
    Cashen AF, Nervi B, DiPersio J
    Future Oncol 2007 Feb;3(1):19-27
  • Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor
    Hess DA, Bonde J, Craft TP, Wirthlin L, Hohm S, Lahey R, Todt LM, DiPersio JF, Devine SM, Nolta JA
    Biol Blood Marrow Transplant 2007 Apr;13(4):398-411
  • Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia
    Link DC, Kunter G, Kasai Y, Zhao Y, Miner T, McLellan MD, Ries RE, Kapur D, Nagarajan R, Dale DC, Bolyard AA, Boxer LA, Welte K, Zeidler C, Donadieu J, Bellanne-Chantelot C, Vardiman JW, Caligiuri MA, Bloomfield CD, DiPersio JF, Tomasson MH, Graubert TA, Westervelt P, Watson M, Shannon W, Baty J, Mardis ER, Wilson RK, Ley TJ
    Blood 2007 Sep 1;110(5):1648-55
  • Prognostic significance of early lymphocyte recovery after post-autografting administration of GM-CSF in non-Hodgkin's lymphoma
    Tiwari D, Gao F, Hidalgo J, Adkins DR, Vij R, DiPersio JF, Khoury HJ
    Bone Marrow Transplant 2007 Oct;40(7):671-5
  • Genetically identical twin transplantation for chronic lymphocytic leukemia
    Pavletic SZ, Zhou G, Sobocinski K, Marti G, Doney K, DiPersio J, Feremans W, Foroni L, Goodman S, Prentice G, LeMaistre C, Bandini G, Ferrant A, Jacobsen N, Khouri I, Gale RP, Wiestner A, Giralt S, Montserrat E, Chan WC, Bredeson C
    Leukemia 2007 Dec;21(12):2452-5
  • Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice
    Nervi B, Rettig MP, Ritchey JK, Wang HL, Bauer G, Walker J, Bonyhadi ML, Berenson RJ, Prior JL, Piwnica-Worms D, Nolta JA, DiPersio JF
    Exp Hematol 2007 Dec;35(12):1823-38
  • A Randomized Double-Blind Trial of Hydroxychloroquine for the Prevention of Chronic Graft-versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation
    Fong T, Trinkaus K, Adkins D, Vij R, Devine SM, Tomasson M, Goodnough LT, Lopez S, Graubert T, Shenoy S, DiPersio JF, Khoury HJ
    Biol Blood Marrow Transplant 2007 Oct;13(10):1201-6
  • Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome
    Fong T, Vij R, Vijayan A, DiPersio J, Blinder M
    Haematologica 2007 Oct;92(10):1429-30
  • Bortezomib inhibits osteoclast activity in patients with multiple myeloma
    Uy GL, Trivedi R, Peles S, Fisher NM, Zhang QJ, Tomasson MH, DiPersio JF, Vij R
    Clin Lymphoma Myeloma 2007 Nov;7(9):587-9
  • Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients
    Verkruyse LA, Storch GA, Devine SM, DiPersio JF, Vij R
    Bone Marrow Transplant 2006 Jan;37(1):51-6
  • Is there a role for high-dose methylprednisolone in the treatment of hepatic regimen-related toxicity?
    Hennenfent KL, Augustin KM, DiPersio JF, Khoury H
    Bone Marrow Transplant 2006 Jan;37(2):229
  • Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage
    Oza A, Hallemeier C, Goodnough L, Khoury H, Shenoy S, Devine S, Augustin K, Vij R, Trinkaus K, DiPersio JF, Adkins D
    Transfusion 2006 Jan;46(1):14-23
  • Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study
    Kantarjian H, Issa JP, Rosenfeld CS, Bennett JM, Albitar M, DiPersio J, Klimek V, Slack J, de Castro C, Ravandi F, Helmer R 3rd, Shen L, Nimer SD, Leavitt R, Raza A, Saba H
    Cancer 2006 Apr 15;106(8):1794-803
  • ASBMT committee report: white paper on measurement of quality outcomes
    Jones RB, Anasetti C, Appel P, DiPersio J, Heslop H, Lemaistre F, Silver S, Sirilla J, Stiff P
    Biol Blood Marrow Transplant 2006 May;12(5):594-7
  • Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabine
    Cashen AF, Devine H, DiPersio J
    Am J Hematol 2006 Jul;81(7):543-5
  • Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide
    Hallemeier CL, Girgis MD, Blum WG, Brown RA, Khoury HJ, Devine SM, Vij R, Lin HS, DiPersio JF, Adkins DR
    Biol Blood Marrow Transplant 2006 Jul;12(7):749-57
  • Cytokines and hematopoietic stem cell mobilization
    Nervi B, Link DC, DiPersio JF
    J Cell Biochem 2006 Oct 15;99(3):690-705
  • Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100
    Shepherd RM, Capoccia BJ, Devine SM, DiPersio J, Trinkaus KM, Ingram D, Link DC
    Blood 2006 Dec 1;108(12):3662-7
  • The activity and toxicity of low dose clofarabine against relapsed or refractory myeloma
    Uy GL, Tomasson MH, Ruddell A, DiPersio JF, Vij R
    Haematologica 2006 Nov;91(11):1581-2
  • Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?
    Dubberke ER, Hollands JM, Georgantopoulos P, Augustin K, DiPersio JF, Mundy LM, Khoury HJ
    Bone Marrow Transplant 2006 Dec;38(12):813-9
  • Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide
    Girgis M, Hallemeier C, Blum W, Brown R, Lin HS, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Oza A, DiPersio J, Adkins D
    Blood 2005 Apr 15;105(8):3035-41
  • A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders
    Shenoy S, Grossman WJ, DiPersio J, Yu LC, Wilson D, Barnes YJ, Mohanakumar T, Rao A, Hayashi RJ
    Bone Marrow Transplant 2005 Feb;35(4):345-52
  • Pilot study of 13cis-retinoic acid+dexamethasone+alpha interferon as maintenance therapy following high-dose chemotherapy and autologous stem cell transplant for multiple myeloma
    Friedman J, Khoury H, Adkins D, Devine S, Nervi B, Edwards T, DiPersio J, Vij R
    Bone Marrow Transplant 2005 May;35(10):979-84
  • The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone
    Flomenberg N, Devine SM, DiPersio JF, Liesveld JL, McCarty JM, Rowley SD, Vesole DH, Badel K, Calandra G
    Blood 2005 Sep 1;106(5):1867-74
  • West Nile Virus encephalopathy in an allogeneic stem cell transplant recipient: use of quantitative PCR for diagnosis and assessment of viral clearance
    Brenner W, Storch G, Buller R, Vij R, Devine S, DiPersio J
    Bone Marrow Transplant 2005 Aug;36(4):369-70
  • Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone
    Devine SM, Brown RA, Mathews V, Trinkaus K, Khoury H, Adkins D, Vij R, Sempek D, Graubert T, Tomasson M, Goodnough LT, DiPersio JF
    Bone Marrow Transplant 2005 Sep;36(6):531-8
  • Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells
    Flomenberg N, DiPersio J, Calandra G
    Acta Haematol 2005;114(4):198-205
  • Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma
    Devine SM, Flomenberg N, Vesole DH, Liesveld J, Weisdorf D, Badel K, Calandra G, DiPersio JF
    J Clin Oncol 2004 Mar 15;22(6):1095-102
  • Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants
    Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Lin HS, DiPersio J, Adkins D
    Biol Blood Marrow Transplant 2004 May;10(5):310-9
  • Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes
    Hidalgo JD, Krone R, Rich MW, Blum K, Adkins D, Fan MY, Brown R, Devine S, Graubert T, Blum W, Tomasson M, Goodnough LT, Vij R, DiPersio J, Khoury H
    Bone Marrow Transplant 2004 Oct;34(7):615-9
  • Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation
    Rettig MP, Ritchey JK, Prior JL, Haug JS, Piwnica-Worms D, DiPersio JF
    J Immunol 2004 Sep 15;173(6):3620-30
  • Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma
    Hoerr AL, Gao F, Hidalgo J, Tiwari D, Blum KA, Mathews V, Adkins DR, Blum W, Devine S, Vij R, Goodnough LT, DiPersio JF, Khoury HJ
    J Clin Oncol 2004 Nov 15;22(22):4561-6
  • Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation
    Vij R, DiPersio JF, Venkatraman P, Trinkaus K, Goodnough LT, Brown RA, Khoury HJ, Devine SM, Oza A, Shenoy S, Blum W, Adkins D
    Blood 2003 Mar 1;101(5):2067-9
  • Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia
    Anderson KB, Tan JS, File TM Jr, DiPersio JF, Willey BM, Low DE
    Clin Infect Dis 2003 Aug 1;37(3):376-81
  • The design and construction of a GMP facility for cellular and gene therapy in an academic center-implementing new regulatory requirements
    Bauer G, Nolta JA, Walker JE, Devine S, DiPersio JF
    Stem Cell and Cell Ther 1:54-61, 2003
  • Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study
    Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, Polish LB
    Infect Control Hosp Epidemiol 2003 Apr;24(4):269-74
  • High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression
    Westervelt P, Lane AA, Pollock JL, Oldfather K, Holt MS, Zimonjic DB, Popescu NC, DiPersio JF, Ley TJ
    Blood 2003 Sep 1;102(5):1857-65
  • High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis
    Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MS, Storek J, Sullivan KM, Al-Omaishi J, Corboy JR, DiPersio J, Georges GE, Gooley TA, Holmberg LA, LeMaistre CF, Ryan K, Openshaw H, Sunderhaus J, Storb R, Zunt J, Kraft GH
    Blood 2003 Oct 1;102(7):2364-72
  • Generation of CD8+ cytotoxic T lymphocytes against breast cancer cells by stimulation with mammaglobin-A-pulsed dendritic cells
    Manna PP, Jaramillo A, Majumder K, Campbell LG, Fleming TP, Dietz JR, DiPersio JF, Mohanakumar T
    Breast Cancer Res Treat 2003 May;79(1):133-6
  • Transduction and selection of human T cells with novel CD34/thymidine kinase chimeric suicide genes for the treatment of graft-versus-host disease
    Rettig MP, Ritchey JK, Meyerrose TE, Haug JS, DiPersio JF
    Mol Ther 2003 Jul;8(1):29-41
  • Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes
    List A, Beran M, DiPersio J, Slack J, Vey N, Rosenfeld CS, Greenberg P
    Leukemia 2003 Aug;17(8):1499-507
  • Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia
    Giles FJ, Fracasso PM, Kantarjian HM, Cortes JE, Brown RA, Verstovsek S, Alvarado Y, Thomas DA, Faderl S, Garcia-Manero G, Wright LP, Samson T, Cahill A, Lambert P, Plunkett W, Sznol M, DiPersio JF, Gandhi V
    Leuk Res 2003 Dec;27(12):1077-83
  • Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation
    Vij R, Khoury H, Brown R, Goodnough LT, Devine SM, Blum W, Adkins D, DiPersio JF
    Bone Marrow Transplant 2003 Oct;32(7):703-7
  • Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases
    Nash RA, Dansey R, Storek J, Georges GE, Bowen JD, Holmberg LA, Kraft GH, Mayes MD, McDonagh KT, Chen CS, DiPersio J, Lemaistre CF, Pavletic S, Sullivan KM, Sunderhaus J, Furst DE, McSweeney PA
    Biol Blood Marrow Transplant 2003 Sep;9(9):583-91
  • Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity
    Chohan R, Vij R, Adkins D, Blum W, Brown R, Tomasson M, Devine S, Graubert T, Goodnough LT, DiPersio JF, Khoury H
    Br J Haematol 2003 Oct;123(1):110-3
  • Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: a feasibility study
    Blum W, Khoury H, Lin HS, Vij R, Goodnough LT, Devine S, DiPersio J, Adkins D
    Biol Blood Marrow Transplant 2003 Jun;9(6):397-404
  • A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes
    Ley TJ, Minx PJ, Walter MJ, Ries RE, Sun H, McLellan M, DiPersio JF, Link DC, Tomasson MH, Graubert TA, McLeod H, Khoury H, Watson M, Shannon W, Trinkaus K, Heath S, Vardiman JW, Caligiuri MA, Bloomfield CD, Milbrandt JD, Mardis ER, Wilson RK
    Proc Natl Acad Sci U S A 2003 Nov 25;100(24):14275-80
  • Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?
    Cashen A, DiPersio JF, Khoury H
    J Clin Oncol 2003 Nov 15;21(22):4255-6
  • Stem cell mobilization
    Cottler-Fox MH, Lapidot T, Petit I, Kollet O, DiPersio JF, Link D, Devine S
    Hematology (Am Soc Hematol Educ Program) 2003;:419-37
  • Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation
    Khoury H, Trinkaus K, Zhang MJ, Adkins D, Brown R, Vij R, Goodnough LT, Ma MK, McLeod HL, Shenoy S, Horowitz M, DiPersio JF
    Biol Blood Marrow Transplant 2003 Nov;9(11):714-21
  • Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia
    Westervelt P, Pollock JL, Oldfather KM, Walter MJ, Ma MK, Williams A, DiPersio JF, Ley TJ
    Proc Natl Acad Sci U S A 2002 Jul 9;99(14):9468-73
  • In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement
    Silverberg D, Kodali P, DiPersio J, Acus R, Askew M
    Clin Orthop Relat Res 2002 Oct;(403):228-31
  • Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer
    Jaramillo A, Majumder K, Manna PP, Fleming TP, Doherty G, DiPersio JF, Mohanakumar T
    Int J Cancer 2002 Dec 10;102(5):499-506
  • Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity
    Blum W, Brown R, Lin HS, Zehnbauer B, Khoury H, Goodnough LT, Westervelt P, Vij R, DiPersio J, Adkins D
    Biol Blood Marrow Transplant 2002;8(11):608-18
  • PCR for the diagnosis of toxoplasmosis after hematopoietic stem cell transplantation
    Lewis JS Jr, Khoury H, Storch GA, DiPersio J
    Expert Rev Mol Diagn 2002 Nov;2(6):616-24
  • Immune hemolysis involving non-ABO/RhD alloantibodies following hematopoietic stem cell transplantation
    Young PP, Goodnough LT, Westervelt P, DiPersio JF
    Bone Marrow Transplant 2001 Jun;27(12):1305-10
  • T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms
    Weitzmann MN, Cenci S, Rifas L, Haug J, DiPersio J, Pacifici R
    J Bone Miner Res 2001 Feb;16(2):328-37
  • Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide
    Westervelt P, Brown RA, Adkins DR, Khoury H, Curtin P, Hurd D, Luger SM, Ma MK, Ley TJ, DiPersio JF
    Blood 2001 Jul 15;98(2):266-71
  • Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin
    Khoury H, Kashyap A, Adkins DR, Brown RA, Miller G, Vij R, Westervelt P, Trinkaus K, Goodnough LT, Hayashi RJ, Parker P, Forman SJ, DiPersio JF
    Bone Marrow Transplant 2001 May;27(10):1059-64
  • Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen
    Khoury H, Adkins D, Brown R, Pence H, Vij R, Goodnough LT, Westervelt P, Trinkaus K, Lin HS, DiPersio J
    Biol Blood Marrow Transplant 2001;7(6):352-8
  • Thrombopoietin therapy increases platelet yields in healthy platelet donors
    Kuter DJ, Goodnough LT, Romo J, DiPersio J, Peterson R, Tomita D, Sheridan W, McCullough J
    Blood 2001 Sep 1;98(5):1339-45
  • Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin
    Goodnough LT, Kuter DJ, McCullough J, Slichter SJ, DiPersio J, Romo J, Peterson R, Smith KJ, Raife T, Tomita D, Armstrong S
    Blood 2001 Sep 1;98(5):1346-51
  • Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial
    Stewart AK, Vescio R, Schiller G, Ballester O, Noga S, Rugo H, Freytes C, Stadtmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyunes M, Jacobs C, Berenson R, White M, DiPersio J, Anderson KC, Berenson J
    J Clin Oncol 2001 Sep 1;19(17):3771-9
  • Interim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer
    Reece DE, Foon KA, Battacharya-Chatterjee M, Adkins D, Broun ER, Connaghan DG, DiPersio JF, Holland HK, Howard DS, Hale GA, Klingemann HG, Munn RK, Raptis A, Phillips GL
    Clin Breast Cancer 2001 Apr;2(1):52-8
  • Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients
    Vescio RA, Wu CH, Zheng L, Sheen D, Ma H, Liu J, Stewart AK, Ballester O, Noga SJ, Rugo H, Freytes C, Stadtmauer E, Sahebi F, Tarantolo S, Stiff P, Schiller GJ, White M, Jacobs C, DiPersio J, Anderson KC, Berenson JR
    Bone Marrow Transplant 2000 Jan;25(2):153-60
  • A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation
    Nash RA, Kurzrock R, DiPersio J, Vose J, Linker C, Maharaj D, Nademanee AP, Negrin R, Nimer S, Shulman H, Ashby M, Jones D, Appelbaum FR, Champlin R
    Biol Blood Marrow Transplant 2000;6(1):25-34
  • Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide
    Duerst RE, Horan JT, Liesveld JL, Abboud CN, Zwetsch LM, Senf ES, Constine LS, Raubertas RF, Passarell JA, DiPersio JF
    Bone Marrow Transplant 2000 Mar;25(5):489-94
  • Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?
    Khoury H, Adkins D, Brown R, Trinkaus K, Vij R, Miller G, Goodnough LT, DiPersio J
    Bone Marrow Transplant 2000 Apr;25(7):737-43
  • Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation
    Adkins DR, Goodnough LT, Shenoy S, Brown R, Moellering J, Khoury H, Vij R, DiPersio J
    Blood 2000 Jun 1;95(11):3605-12
  • B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta
    Weitzmann MN, Cenci S, Haug J, Brown C, DiPersio J, Pacifici R
    J Cell Biochem 2000 May;78(2):318-24
  • Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation
    Khoury H, Adkins D, Brown R, Vij R, Westervelt P, Trinkaus K, Goodnough LT, DiPersio JF
    Bone Marrow Transplant 2000 Jun;25(11):1197-201
  • Allogeneic peripheral blood stem cell transplantation following CD34+ enrichment by density gradient separation
    Vij R, Brown R, Shenoy S, Haug JS, Kaesberg D, Adkins D, Goodnough LT, Khoury H, DiPersio J
    Bone Marrow Transplant 2000 Jun;25(12):1223-8
  • Mobilization of peripheral-blood stem cells by concurrent administration of daniplestim and granulocyte colony-stimulating factor in patients with breast cancer or lymphoma
    DiPersio JF, Schuster MW, Abboud CN, Winter JN, Santos VR, Collins DM, Sherman JW, Baum CM
    J Clin Oncol 2000 Jul;18(14):2762-71
  • Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation
    Vij R, DiPersio J, Brown R, Trinkaus K, Abboud C, Meehan KR, Frenette G, Freytes C, Goodnough LT, Khoury H, Ponnuri J, Adkins D
    Bone Marrow Transplant 2000 Nov;26(9):947-53
  • Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy
    Adkins DR, Abidi MH, Brown RA, Khoury H, Goodnough LT, Vij R, Westervelt P, DiPersio JF
    Bone Marrow Transplant 2000 Dec;26(11):1239-41
  • Assays to determine hematopoietic stem cell content in blood and marrow grafts
    Verfaillie CM, Ploemacher R, Di Persio J, Sutherland R, Serke S, Johnsen H, Noga S, Negrin R
    Cytotherapy 1999;1(1):41-9
  • Economic impact of donor platelet count and platelet yield in apheresis products: relevance for emerging issues in platelet transfusion therapy
    Goodnough LT, Ali S, Despotis G, Dynis M, DiPersio JF
    Vox Sang 1999;76(1):43-9
  • Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma
    Vescio R, Schiller G, Stewart AK, Ballester O, Noga S, Rugo H, Freytes C, Stadtmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyunes M, Jacobs C, Berenson R, DiPersio J, Anderson K, Berenson J
    Blood 1999 Mar 15;93(6):1858-68
  • Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality
    Brown RA, Adkins D, Khoury H, Vij R, Goodnough LT, Shenoy S, DiPersio JF
    J Clin Oncol 1999 Mar;17(3):806-12
  • Immune reconstitution following allogeneic peripheral blood stem cell transplants
    Shenoy S, Mohanakumar T, Todd G, Westhoff W, Dunnigan K, Adkins DR, Brown RA, DiPersio JF
    Bone Marrow Transplant 1999 Feb;23(4):335-46
  • Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: contribution of a PCR test in diagnosis and early detection
    Khoury H, Adkins D, Brown R, Goodnough L, Gokden M, Roberts T, Storch G, DiPersio J
    Bone Marrow Transplant 1999 Feb;23(4):409-11
  • Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte-colony-stimulating factor
    Vij R, Adkins DR, Brown RA, Khoury H, DiPersio JF, Goodnough T
    Transfusion 1999 May;39(5):542-3
  • Mammaglobin expression in primary, metastatic, and occult breast cancer [In Process Citation]
    Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R, Fleming TP
    Cancer Res 1999 Jul 1;59(13):3028-31
  • Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells
    Krieger MS, Schiller G, Berenson JR, Stewart K, Noga SJ, Ballester O, Tarantolo S, Stiff P, Kuhn D, Scherzo E, Sing A, Jacobs C, White JM, DiPersio J
    Bone Marrow Transplant 1999 Jul;24(1):25-8
  • Tularemia--an unusual cause of a solitary pulmonary nodule in the post-transplant setting
    Naughton M, Brown R, Adkins D, DiPersio J
    Bone Marrow Transplant 1999 Jul;24(2):197-9
  • Donor-derived acute promyelocytic leukemia in a liver-transplant recipient
    Bodo I, Peters M, Radich JP, Hess J, Blinder M, Watson MS, Van Rheeden R, Natarajan S, Lowell JA, Brown R, DiPersio J, Adkins D
    N Engl J Med 1999 Sep 9;341(11):807-13
  • Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants
    Liesveld J, Duerst R, Rapoport A, Constine L, Abboud C, Packman C, Wedow L, Zwetsch L, McKenna B, Linder T, Silverman W, Swift S, Rowe J, DiPersio J
    Bone Marrow Transplant 1999 Sep;24(5):511-6
  • Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer
    Adkins D, Brown R, Trinkaus K, Maziarz R, Luedke S, Freytes C, Needles B, Wienski D, Fracasso P, Pluard T, Moriconi W, Ryan T, Hoelzer K, Safdar S, Rearden T, Rodriguez G, Khoury H, Vij R, DiPersio J
    J Clin Oncol 1999 Jul;17(7):2006-14
  • Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex
    Rowe JM, Rapoport AP, Ryan DH, Nilsson BI, Duerst RE, Packman CH, Abboud CN, DiPersio JF, Linder T, Wang N, Simonsson B, Liesveld JL
    Bone Marrow Transplant 1999 Nov;24(10):1057-63
  • Ex vivo cultured megakaryocytes express functional glycoprotein IIb-IIIa receptors and are capable of adenovirus-mediated transgene expression
    Faraday N, Rade JJ, Johns DC, Khetawat G, Noga SJ, DiPersio JF, Jin Y, Nichol JL, Haug JS, Bray PF
    Blood 1999 Dec 15;94(12):4084-92
  • Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation
    Adkins D, Brown R, Goodnough LT, Khoury H, Popovic W, DiPersio J
    Bone Marrow Transplant 1998 Jan;21(1):97-9
  • Patient selection in high-dose trials of breast cancer [letter; comment]
    Adkins DR, Brown RA, DiPersio JF
    J Clin Oncol 1998 Mar;16(3):1238-9
  • A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation
    Bernstein SH, Nademanee AP, Vose JM, Tricot G, Fay JW, Negrin RS, DiPersio J, Rondon G, Champlin R, Barnett MJ, Cornetta K, Herzig GP, Vaughan W, Geils G Jr, Keating A, Messner H, Wolff SN, Miller KB, Linker C, Cairo M, Hellmann S, Ashby M, Stryker S, Nash RA
    Blood 1998 May 1;91(9):3509-17
  • Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia
    Khoury H, Adkins D, Zehnbauer B, Goodnough L, Brown R, Safdar S, DiPersio JF
    Bone Marrow Transplant 1998 Jul;22(1):107-9
  • Autotransplantation for relapsed or refractory Hodgkin's disease: long- term follow-up and analysis of prognostic factors
    Lancet JE, Rapoport AP, Brasacchio R, Eberly S, Raubertas RF, Linder T, Muhs A, Duerst RE, Abboud CN, Packman CH, DiPersio JF, Constine LS, Rowe JM, Liesveld JL
    Bone Marrow Transplant 1998 Aug;22(3):265-71
  • Granulocyte-macrophage colony-stimulating factor with induction treatment of acute myelogenous leukemia [letter; comment]
    Adkins DR, Brown RA, DiPersio JF
    J Clin Oncol 1997 Feb;15(2):862-3
  • Autotransplantation for relapsed or refractory non-Hodgkin's lymphoma (NHL): long-term follow-up and analysis of prognostic factors
    Rapoport AP, Lifton R, Constine LS, Duerst RE, Abboud CN, Liesveld JL, Packman CH, Eberly S, Raubertas RF, Martin BA, Flesher WR, Kouides PA, DiPersio JF, Rowe JM
    Bone Marrow Transplant 1997 May;19(9):883-90
  • Familial transmission of a serious disease--producing group A streptococcus clone: case reports and review
    Gamba MA, Martinelli M, Schaad HJ, Streuli RA, DiPersio J, Matter L, Ris HB, Marchal F, Kaplan EL, Stevens DL, Malinverni R
    Clin Infect Dis 1997 Jun;24(6):1118-21
  • Resolution of invasive central nervous system aspergillosis in a transplant recipient [see comments]
    Khoury H, Adkins D, Miller G, Goodnough L, Brown R, DiPersio J
    Bone Marrow Transplant 1997 Jul;20(2):179-80
  • Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation
    Graubert TA, DiPersio JF, Russell JH, Ley TJ
    J Clin Invest 1997 Aug 15;100(4):904-11
  • Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies
    Brown RA, Adkins D, Goodnough LT, Haug JS, Todd G, Wehde M, Hendricks D, Ehlenbeck C, Laub L, DiPersio J
    J Clin Oncol 1997 Sep;15(9):3067-74
  • Mutational analysis of the alpha subunit of the human interleukin-3 receptor
    Rapoport AP, Luhowskyj S, Doshi P, DiPersio JF
    Blood 1996 Jan 1;87(1):112-22
  • Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells
    Matayoshi A, Brown C, DiPersio JF, Haug J, Abu-Amer Y, Liapis H, Kuestner R, Pacifici R
    Proc Natl Acad Sci U S A 1996 Oct 1;93(20):10785-90
  • Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature
    Martin BA, Rowe JM, Kouides PA, DiPersio JF
    Bone Marrow Transplant 1995 Jan;15(1):145-8
  • Leukodepleted-ABO-identical blood components in the treatment of hematologic malignancies: a cost analysis
    Blumberg N, Heal JM, Kirkley SA, DiPersio JF, Rapoport AP, Rowe JM
    Am J Hematol 1995 Feb;48(2):108-15
  • Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years
    Rapoport AP, DiPersio JF, Martin BA, Duerst RE, Kouides PA, Liesveld JL, Abboud CN, Packman CH, Eberly SW, Sherman M, et al
    Bone Marrow Transplant 1995 Apr;15(4):523-30
  • Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest
    Wilhide CC, Van Dang C, DiPersio J, Kenedy AA, Bray PF
    Blood 1995 Jul 1;86(1):294-304
  • Roquinimex-induced graft-versus-host reaction after autologous bone marrow transplantation
    Gaspari AA, Cheng SF, DiPersio JF, Rowe JM
    J Am Acad Dermatol 1995 Nov;33(5 Pt 1):711-7
  • Integrins and adhesive receptors in normal and leukemic CD34+ progenitor cells: potential regulatory checkpoints for cellular traffic
    Liesveld JL, DiPersio JF, Abboud CN
    Leuk Lymphoma 1994 Jun;14(1-2):19-28
  • CD34+ progenitor cell isolation from blood and marrow: a comparison of techniques for small-scale selection
    Winslow JM, Liesveld JL, Ryan DH, DiPersio JF, Abboud CN
    Bone Marrow Transplant 1994 Aug;14(2):265-71
  • Effects of GM-CSF on Ki67 expression and cell cycle traverse in acute myelogenous leukemia specimens and cell lines
    Liesveld JL, Keng PC, Rowe JM, DiPersio JF, Abboud CN
    Leuk Res 1994 Aug;18(8):609-16
  • Three conserved motifs in the extracellular domain of the human granulocyte-macrophage colony-stimulating factor receptor subunit are essential for ligand binding and surface expression
    Doshi PD, DiPersio JF
    Blood 1994 Oct 15;84(8):2539-53
  • Characterization of the adherence of normal and leukemic CD34+ cells to endothelial monolayers
    Liesveld JL, Frediani KE, Harbol AW, DiPersio JF, Abboud CN
    Leukemia 1994 Dec;8(12):2111-7
  • Leukocyte-reduced transfusions of ABO-identical platelets and clinical outcome in autologous bone marrow transplantation for lymphoma
    Heal JM, Blumberg N, Kirkley SA, DiPersio JF, Rapoport AP, Rowe JM
    Bone Marrow Transplant 1994 Dec;14(6):943-8
  • One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome
    Rapoport AP, Rowe JM, Kouides PA, Duerst RA, Abboud CN, Liesveld JL, Packman CH, Eberly S, Sherman M, Tanner MA, DiPersio JF
    J Clin Oncol 1993 Dec;11(12):2351-61
  • Treatment of chronic myelogenous leukemia with autologous bone-marrow transplantation followed by the immunomodulator roquinimex (linomide)
    Rowe JM, Ryan DH, DiPersio JF
    Exp Hematol 1993;21:1020
  • Autografting in chronic myelogenous leukemia followed by immunotherapy
    Rowe J, Ryan D, DiPersio J, Gaspari A, Nilsson B, Larsson L, Liesveld J, Kouides P, Simonsson B
    Stem Cells (Dayt) 1993 Oct;11 Suppl 3:34-42
  • Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration
    Kohn EC, Hollister GH, DiPersio JF, Wahl S, Liotta LA, Schiffmann E
    Int J Cancer 1993 Apr 1;53(6):968-72
  • Sequence analysis and functional studies of interleukin-3 receptor alpha subunit-encoding cDNAs amplified from KG-1 leukemic cells and normal human marrow
    Rapoport AP, DiPersio JF
    Gene 1993 Dec 31;137(2):333-7
  • Treatment of relapsed or refractory Hodgkin disease and non-Hodgkin lymphoma with high-dose chemoradiotherapy followed by unstimulated autologous peripheral stem cell rescue
    Rapoport AP, Rowe JM, Heal JM, Tanner MA, DiPersio JF
    Am J Hematol 1992 Jun;40(2):86-92
  • Characterization of the soluble human granulocyte-macrophage colony- stimulating factor receptor complex
    DiPersio JF, Hedvat C, Ford CF, Golde DW, Gasson JC
    J Biol Chem 1991 Jan 5;266(1):279-86
  • Identification and molecular cloning of a soluble human granulocyte- macrophage colony-stimulating factor receptor
    Raines MA, Liu L, Quan SG, Joe V, DiPersio JF, Golde DW
    Proc Natl Acad Sci U S A 1991 Sep 15;88(18):8203-7
  • Involvement of tyrosine kinases in the activation of human peripheral blood neutrophils by granulocyte-macrophage colony-stimulating factor
    McColl SR, DiPersio JF, Caon AC, Ho P, Naccache PH
    Blood 1991 Oct 1;78(7):1842-52
  • Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant
    Rapoport AP, Doyle HR, Starzl T, Rowe JM, Doeblin T, DiPersio JF
    Bone Marrow Transplant 1991 Nov;8(5):421-4
  • The biology of human granulocyte-macrophage colony-stimulating factor (GM-CSF)
    Gasson JC, Baldwin GC, Sakamoto KM, DiPersio JF
    Prog Clin Biol Res 1990;352:375-84
  • Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines
    Avalos BR, Gasson JC, Hedvat C, Quan SG, Baldwin GC, Weisbart RH, Williams RE, Golde DW, DiPersio JF
    Blood 1990 Feb 15;75(4):851-7
  • Involvement of guanine nucleotide binding proteins in neutrophil activation and priming by GM-CSF
    McColl SR, Kreis C, DiPersio JF, Borgeat P, Naccache PH
    Blood 1989 Feb;73(2):588-91
  • Nonhematopoietic tumor cells express functional GM-CSF receptors
    Baldwin GC, Gasson JC, Kaufman SE, Quan SG, Williams RE, Avalos BR, Gazdar AF, Golde DW, DiPersio JF
    Blood 1989 Mar;73(4):1033-7
  • Effects of human GM-CSF on neutrophil degranulation in vitro
    Kaufman SE, DiPersio JF, Gasson JC
    Exp Hematol 1989 Aug;17(7):800-4
  • Characterization of the human granulocyte-macrophage colony-stimulating factor receptor
    DiPersio J, Billing P, Kaufman S, Eghtesady P, Williams RE, Gasson JC
    J Biol Chem 1988 Feb 5;263(4):1834-41
  • Granulocyte-macrophage colony-stimulating factor modulates the excitation-response coupling sequence in human neutrophils
    Naccache PH, Faucher N, Borgeat P, Gasson JC, DiPersio JF
    J Immunol 1988 May 15;140(10):3541-6
  • Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis
    DiPersio JF, Billing P, Williams R, Gasson JC
    J Immunol 1988 Jun 15;140(12):4315-22
  • Characterization of the priming effects of human granulocyte-macrophage colony-stimulating factor on human neutrophil leukotriene synthesis
    DiPersio JF, Naccache PH, Borgeat P, Gasson JC, Nguyen MH, McColl SR
    Prostaglandins 1988 Nov;36(5):673-91
  • Tumor necrosis factor: receptors on hematopoietic cells
    Munker R, DiPersio J, Koeffler HP
    Blood 1987 Dec;70(6):1730-4
  • Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor
    Silberstein DS, Owen WF, Gasson JC, DiPersio JF, Golde DW, Bina JC, Soberman R, Austen KF, David JR
    J Immunol 1986 Nov 15;137(10):3290-4
  • Autostimulation of growth by human myelogenous leukemia cells (HL-60)
    Brennan JK, Abboud CN, DiPersio JF, Barlow GH, Lichtman MA
    Blood 1981 Oct;58(4):803-12
  • Erythropoietic enhancing activity (EEA) secreted by the human cell line, GCT
    Abboud CN, DiPersio JF, Brennan JK, Lichtman MA
    J Supramol Struct 1980;13(2):199-209
  • Chemical mediators of granulopoiesis: a review
    Brennan JK, Lichtman MA, DiPersio JF, Abboud CN
    Exp Hematol 1980 Apr;8(4):441-64
  • The fractionation, characterization, and subcellular localization of colony-stimulating activities released by the human monocyte-like cell line, GCT
    DiPersio JF, Brennan JK, Lichtman MA, Abboud CN, Kirkpatrick FH
    Blood 1980 Oct;56(4):717-27
  • The exceptional responsiveness of certain human myeloid leukemia cells to colony-stimulating activity
    Brennan JK, DiPersio JF, Abboud CN, Lichtman MA
    Blood 1979 Dec;54(6):1230-9
  • Human cell lines that elaborate colon-stimulating activity for the marrow cells of man and other species
    DiPersio JF, Brennan JK, Lichtman MA, Speiser BL
    Blood 1978 Mar;51(3):507-19